II期双胎输血综合征伴供血儿间歇性脐动脉异常的血流结局
本研究回顾2006-2023年接受激光手术的单绒毛膜双羊膜囊双胎输血综合征病例,比较II期供血儿脐动脉正常波形、II期间歇性脐动脉舒张末期血流缺失或反向(UA-AREDF)与III期持续性UA-AREDF三组的结局。结果显示II期间歇性组供血儿宫内死亡风险未显著高于II期正常组(aOR 0.51,95%CI 0.15-1.79),支持仅将持续性UA-AREDF归为III期的传统Quintero分期。
要点
- II期TTTS伴间歇性供血儿UA-AREDF的供血儿IUFD风险与II期UA波形正常者无显著差异。
- III期持续性供血儿UA-AREDF的供血儿IUFD率显著高于II期两组。
- 结果支持传统Quintero分期:仅持续性UA-AREDF归为III期。
核心结论
- II期TTTS伴间歇性供血儿UA-AREDF患者激光术后供血儿IUFD风险未较II期UA正常者增加。
- 研究结果支持传统Quintero分期,仅将持续性UA-AREDF归为III期。
研究设计与样本
- 回顾性分析2006-2023年接受激光手术的单绒毛膜双羊膜囊TTTS三组病例。
- 分组为II期正常波形(n=126)、II期间歇性UA-AREDF(n=62)和III期持续性供血儿UA-AREDF(n=212)。
- 采用双变量分析和多因素logistic回归模型,主要结局为供血儿宫内死亡。
主要发现
- II期正常、II期间歇性和III期三组供血儿IUFD率分别为7.1%、8.1%和29.2%(P<.0001)。
- 三组双胎存活率分别为84.1%、82.3%和62.7%(P<.0001)。
- 多因素调整后,II期间歇性组较II期正常组的供血儿IUFD风险aOR为0.51(95%CI 0.15-1.79)。
关键数值与推荐
- 供血儿间歇性UA-AREDF归为I期(膀胱可见)或II期(膀胱不可见),持续性UA-AREDF归为III期。
- II期间歇性组与II期正常组供血儿IUFD风险无显著差异(aOR 0.51,95%CI 0.15-1.79)。
- III期供血儿IUFD率29.2%,双胎存活率62.7%。
临床怎么用
- II期TTTS伴间歇性供血儿UA-AREDF可按传统Quintero分期管理,不因间歇性波形升级为III期。
- 激光术前评估供血儿UA波形时需区分间歇性与持续性UA-AREDF。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Twin-twin transfusion syndrome (TTTS) is a rare condition of monochorionic diamniotic twin pregnancies. The Quintero staging system was established to categorize the severity of this disease. Published outcomes for selective laser photocoagulation of communicating vessels (SLPCV) demonstrate a significant difference in dual survival outcomes among the different stages of TTTS. Intermittent donor umbilical artery (UA) absent or reversed end diastolic flow (AREDF) is classified as stage I (donor bladder visible) or II (donor bladder not visible), whereas persistent donor twin UA-AREDF is classified as stage III. This distinction between intermittent and persistent UA-AREDF appears to have been variably interpreted since the original publication. OBJECTIVE: We evaluated laser surgery outcomes in 3 groups: stage II patients with intermittent UA-AREDF (Stage -II intermittent) vs stage II patients with a normal UA waveform (Stage II-Normal), using stage III patients with persistent donor twin UA-AREDF (Stage-III) for comparison. STUDY DESIGN: Three groups of monochorionic diamniotic twins with TTTS treated with laser surgery (2006-2023) were analyzed: (1) Stage-II Normal; (2) Stage-II Intermittent; and (3) Stage-III (Stage III Donor + Stage-III Donor/Recipient). The groups were compared in bivariate analysis and in a multiple logistic regression model for the primary outcome of donor twin intrauterine fetal demise (IUFD). RESULTS: For Stage-II Normal (n=126), Stage-II Intermittent (n=62), and Stage-III (n=212), respective rates of donor IUFD were 7.1% vs 8.1% vs 29.2% (P<.0001), and dual survivorship was 84.1% vs 82.3% vs 62.7% (P<.0001). Multiple covariates were eligible for inclusion in the logistic regression model, including gestational age at the procedure, the preoperative estimated fetal weight of the donor, and the presence of arterioarterial anastomoses (AA). Upon adjustment in a multiple logistic regression model, the Stage-II Intermittent group did not have an increased risk of donor IUFD vs Stage-II Normal (aOR 0.51, 95% CI 0.15-1.79). CONCLUSION: TTTS stage II patients with intermittent UA-AREDF did not show increased risk of donor IUFD compared with stage II patients with normal UA Doppler findings. These results support the traditional Quintero staging classification, which classifies only persistent UA-AREDF as stage III TTTS.
引用
- Sun RC, Chon AH, Korst LM, et al. Outcomes in Stage II twin-twin transfusion syndrome with donor intermittent umbilical artery Doppler abnormalities. Am J Obstet Gynecol MFM. 2026. PMID: 42982129. doi:10.1016/j.ajogmf.2026.102190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。